<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref25">
 <mixed-citation publication-type="journal" id="cit25">
  <name>
   <surname>Goto</surname>
   <given-names>Y.</given-names>
  </name>; 
  <name>
   <surname>Bhatia</surname>
   <given-names>A.</given-names>
  </name>; 
  <name>
   <surname>Raman</surname>
   <given-names>V. S.</given-names>
  </name>; 
  <name>
   <surname>Vidal</surname>
   <given-names>S. E.</given-names>
  </name>; 
  <name>
   <surname>Bertholet</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Coler</surname>
   <given-names>R. N.</given-names>
  </name>; 
  <name>
   <surname>Howard</surname>
   <given-names>R. F.</given-names>
  </name>; 
  <name>
   <surname>Reed</surname>
   <given-names>S. G.</given-names>
  </name>
  <article-title>Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infection</article-title>. 
  <source>Vaccine</source>
  <year>2009</year>, 
  <volume>27</volume>, 
  <fpage>2884</fpage>â€“
  <lpage>2890</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2009.02.079</pub-id>.
  <pub-id pub-id-type="pmid">19428898</pub-id>
 </mixed-citation>
</ref>
